Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move- CSE: $MTEC.C,
CSE: $CROP.C, CSE: $RQB.C
July 13th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –July 13, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07132Potcasts-CSE-MTEC-CROP-RQB.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast ; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news announcements from Cannvas MedTech
Inc. trading on the CSE as
MTEC, CROP Infrastructure Corp.
trading on the CSE as CROP and the OTC as CRXPF and RavenQuest BioMed Inc. trading on the CSE as RQB and the OTCQB as RVVQF.
Cannvas MedTech Inc., a leading
business technology company within the cannabis space, announced that it has
acquired over 650 online domains since the inception of the Company. The
majority of these domains will be used for marketing awareness and customer
acquisition as the Company rolls out its global expansion plan for the
Cannvas.me platform.
"Our
domain strategy is one of many important components of an overall global
marketing plan, as we begin the socialization of our cannabis education
platform with a goal of achieving user acquisition targets," said Steve
Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc.
"Marketing and customer acquisition efforts will be further emphasized
through targeted CRM strategies as the Cannvas.me platform is phased into
global markets. Reaching a broad base of users and engaging them through
meaningful and contextual content will ensure a healthy base for deriving
cannabis sector insights on a global economic scale, directly tying into our
financial partnership models for company growth targets and positive financial
outcomes."
CROP Infrastructure Corp. announced
that its tenant grower “The Hempire Company, LLC” has been issued a formal
Nevada hemp licence covering all 240 pivoted acres of CROP’s Nye County, Nevada
farm. Planting has been completed on 120 acres and is now underway on an
additional 120 acres, consisting of only approved organic and natural materials
in agriculture production in order to be deemed an Organic operation.
The Nye
County agricultural Hemp farm is located in central Nevada and was selected for
its temperate climate which is ideal for greenhouse and outdoor growing. The
property totals over 315 acres and includes 300 acres of private water rights,
with 240 acres under automatic irrigation pivots that also have automatic
fertilizer injection systems installed.
The genetics
selected, BaOx and Cherry BaOX have a THC content of <0.3% and a CBD content
of >15%. It is estimated that the 240 acre pivots will yield 240,000 pounds
of hemp flower. Cost of production is not expected to exceed $700,000 USD.
The first harvest is expected in early Q4 this year.
RavenQuest BioMed Inc. has
completed its previously announced non-brokered private placement of units.
In connection with completion of the placement, the Company issued
11,504,937 units at a price of $0.70 per Unit, for aggregate gross proceeds of
$8,053,455.90.
“We are
thrilled to see that the offering was oversubscribed, demonstrating the
high-level of confidence that the market has in our Company’s unique
combination of innovation, strategic vision and execution” stated George
Robinson, Chief Executive Officer of RavenQuest. “Having successfully
unveiled our Orbital Garden grow-methodology to the marketplace and announced
an MOU to sell all of our Bloomera production to BCLDB, we feel we have
significantly de-risked our story, representing a tremendous opportunity for
our shareholders” Robinson continued.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment